# Abbott Q3 Revenue Reaches $13.01 Billion, Exceeds Estimates By John Kim Canonical URL: https://www.tokenpost.com/news/business/37083 Published: 2026-10-21T22:04:24.000Z Updated: 2026-10-21T22:04:24.000Z Section: Business > Adjusted diluted earnings were $1.42 per share, topping estimates by $0.01. Abbott reaffirmed its 2026 earnings outlook. Abbott Laboratories posted third-quarter revenue of $13.01 billion, exceeding estimates by about $20 million, and reaffirmed its 2026 adjusted earnings outlook after a small per-share earnings beat. Revenue rose 14.4% from a year earlier. Adjusted diluted earnings reached $1.42 per share, $0.01 above estimates. Abbott maintained its full-year adjusted diluted earnings guidance at $5.50 to $5.55 per share. The quarterly earnings result fell within [Abbott’s earlier forecast of $1.38 to $1.46 per share](). The $1.42 result was $0.04 above the bottom of that range and $0.04 below the top. In the second quarter, Abbott recorded $12.59 billion in sales and adjusted diluted earnings of $1.31 per share. Its third-quarter revenue and adjusted earnings were higher than those prior-quarter figures. ## Links in this article - [Abbott’s earlier forecast of $1.38 to $1.46 per share](https://www.tokenpost.com/news/business/36182)